The effectiveness of Clopidogrel BMS as an anticoagulant was compared with that of aspirin in a study called CAPRIE including around 19,000 patients with atherothrombosis.
Clopidogrel BMSin tehoa antikoagulanttina aspiriiniin verrattuna on tutkittu tutkimuksessa (CAPRIE), johon osallistui noin 19 000 valtimotukospotilasta.